Balaji Wafers, the Rajkot-headquartered snack maker, is in discussions with top private equity (PE) firms to divest up to 10 per cent of its equity at a valuation of nearly Rs 40,000 crore ($4.53 billion), according to Business Standard, which cited people aware of the development.The company, established by the Virani brothers — Chandubhai, Bhikhubhai, and Kanubhai — is exploring this partial...

Dalal Street opened the first trading session of the week on a flat note, as heightened caution kept investors on edge on Monday, September 8, as ongoing tariff concerns weighed on sentiment.At 09:15 a.m., the Sensex was up 288.85 points or 0.36 percent at 80,999.61, and the Nifty was up 83.10 points or 0.34 percent at 24,824.10.Sectoral indices were trading higher with gains led by Nifty Metal (u...

Zydus Lifescience share price will remain in focus on September 8 following the US regulator issued four observations to the company's Vadodara unit.The United States Food and Drug Administration (USFDA) conducted an inspection at the group’s injectable manufacturing plant at Jarod, near Vadodara, Gujarat.The US regulator issued four observations post completing inspection from August 25, to Sep...

Aurobindo Pharma share will remain in focus on September 8 following the company received eight observations from the United States Food and Drug Administration (USFDA).The USFDA inspected company's Unit-XII, including oral solids and injectable manufacturing unit, situated at Bachupally, Medchal Malkajgiri District, Telangana from August 25 to September 05, 2025.At the end of the current inspecti...

An exchange filing by Glenmark said that it has received approval from the Drugs Controller General of India (DCGI) to commence patient enrollment and dosing in India.Pharma major Glenmark has started a multi-country Phase 3 clinical trial for Envafolimab, an oncology drug that is currently being used in China for treatment of tumors, the company said in an exchange filing on September 5, sending ...